Does prolonged infusion allow lower daily dose of meropenem than bolus dosing?
نویسندگان
چکیده
s of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco (CA). Washington (DC): American Society for Microbiology; 1993. 6. Lomaestro BM, Drusano GL. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation. Antimicrob Agents Chemother 2005;49(1):461-463. 7. Kuti JL, Dandekar PK, Nightingale CH, Nicolau DP. Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem. J Clin Pharmacol 2003;43(10):1116-1123. Erratum in: J Clin Pharmacol 2005;45(3):357. 8. Itabashi S. [Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia]. Jpn J Antibiot 2007;60(3):
منابع مشابه
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
OBJECTIVES To compare the plasma and subcutaneous tissue concentration-time profiles of meropenem administered by intermittent bolus dosing or continuous infusion to critically ill patients with sepsis and without renal dysfunction, and to use population pharmacokinetic modelling and Monte Carlo simulations to assess the cumulative fraction of response (CFR) against Gram-negative pathogens like...
متن کاملClinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
INTRODUCTION Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill patients with severe infection, and to evaluate the safety of both dosing regim...
متن کاملPharmacokinetics and pharmacodynamics of meropenem in children with severe infection.
This study aimed to describe the pharmacokinetic (PK) characteristics of meropenem in children with severe infections and to assess the pharmacokinetic/pharmacodynamic (PK/PD) profiles of various meropenem dosage regimens in these patients. Fourteen children with severe infections received intravenous (i.v.) bolus doses of meropenem (20 mg/kg/dose) every 8 h (q8h). Serum samples were obtained b...
متن کاملShort versus long infusion of meropenem in very-low-birth-weight neonates.
Prolonged infusion of meropenem has been suggested in studies with population pharmacokinetic modeling but has not been tested in neonates. We compared the steady-state pharmacokinetics (PK) of meropenem given as a short (30-min) or prolonged (4-h) infusion to very-low-birth-weight (gestational age, <32 weeks; birth weight, <1,200 g) neonates to define the appropriate dosing regimen for a phase...
متن کاملMeropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge
We agree with the recent commentary of GonçalvesPereira and Oliveira refuting a ‘one size fits all’ paradigm of antibiotic dosing in patients subjected to extracorporeal circulation [1] but want to focus somewhat further on meropenem pharmacokinetics (PK). Meropenem has optimal bactericidal activity if plasma levels remain above the minimum inhibitory concentration of the pathogen for at least ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Canadian journal of hospital pharmacy
دوره 62 6 شماره
صفحات -
تاریخ انتشار 2009